John Schulte

Mr. Schulte has broad experience leading medical device companies, ranging from startups to publicly traded companies and divisions of Fortune 500 companies. He has been President of 3 separate divisions of CR Bard, President of the Surgical Division of Genzyme and President and CEO of Spectranetics Corporation. He was also CEO of Mitralign, and Executive Chairman of Cardiofocus, two privately held cardiovascular companies. Mr. Schulte has a BA from the College of the Holy Cross and an MBA from Boston University.